Ensuring Product Stability: The Necessity of Polysorbate Degradation Analysis in Biopharma
Technical Reference Summary
Covered Models & Document Scope
White paper on polysorbate degradation analysis in biopharma; covers regulatory status of polysorbates 20 and 80 and analytical methods, including the Agilent AdvanceBio Surfactant profiling HPLC column. No model/size/ordering variants.
Operating Limits
- Polysorbate 80 oleic acid composition (Chinese Pharmacopoeia): at least 98% p.2 ↗
- Polysorbate 80 remaining fatty acids (linoleic, palmitic, palmitoleic, stearic, myristic, linolenic) each (Chinese Pharmacopoeia): no more than 0.5% each p.2 ↗
- Polysorbate 80 oleic acid composition (European, Japanese, U.S. Pharmacopeias): at least 58% p.2 ↗